BRD4 facilitates replication stress-induced DNA damage response

Jingwen Zhang, Austin M. Dulak, Maureen M. Hattersley, Brandon S. Willis, Jenni Nikkilä, Anderson Wang, Alan Lau, Corinne Reimer, Michael Zinda, Stephen E. Fawell, Gordon Mills, Huawei Chen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Previous reports have demonstrated that select cancers depend on BRD4 to regulate oncogenic gene transcriptional programs. Here we describe a novel role for BRD4 in DNA damage response (DDR). BRD4 associates with and regulates the function of pre-replication factor CDC6 and plays an indispensable part in DNA replication checkpoint signaling. Inhibition of BRD4 by JQ1 or AZD5153 resulted in a rapid, time-dependent reduction in CHK1 phosphorylation and aberrant DNA replication re-initiation. Furthermore, BRD4 inhibition sensitized cancer cells to various replication stress-inducing agents, and synergized with ATR inhibitor AZD6738 to induce cell killing across a number of cancer cell lines. The synergistic interaction between AZD5153 and AZD6738 is translatable to in vivo ovarian cell-line and patient-derived xenograft models. Taken together, our study uncovers a new biological function of BRD4 and provides mechanistic rationale for combining BET inhibitors with DDR-targeted agents for cancer therapy.

Original languageEnglish (US)
Pages (from-to)1-15
Number of pages15
JournalOncogene
DOIs
StateAccepted/In press - Apr 11 2018
Externally publishedYes

Fingerprint

DNA Damage
DNA Replication
Neoplasms
Cell Line
Heterografts
Phosphorylation
Genes
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Zhang, J., Dulak, A. M., Hattersley, M. M., Willis, B. S., Nikkilä, J., Wang, A., ... Chen, H. (Accepted/In press). BRD4 facilitates replication stress-induced DNA damage response. Oncogene, 1-15. https://doi.org/10.1038/s41388-018-0194-3

BRD4 facilitates replication stress-induced DNA damage response. / Zhang, Jingwen; Dulak, Austin M.; Hattersley, Maureen M.; Willis, Brandon S.; Nikkilä, Jenni; Wang, Anderson; Lau, Alan; Reimer, Corinne; Zinda, Michael; Fawell, Stephen E.; Mills, Gordon; Chen, Huawei.

In: Oncogene, 11.04.2018, p. 1-15.

Research output: Contribution to journalArticle

Zhang, J, Dulak, AM, Hattersley, MM, Willis, BS, Nikkilä, J, Wang, A, Lau, A, Reimer, C, Zinda, M, Fawell, SE, Mills, G & Chen, H 2018, 'BRD4 facilitates replication stress-induced DNA damage response', Oncogene, pp. 1-15. https://doi.org/10.1038/s41388-018-0194-3
Zhang J, Dulak AM, Hattersley MM, Willis BS, Nikkilä J, Wang A et al. BRD4 facilitates replication stress-induced DNA damage response. Oncogene. 2018 Apr 11;1-15. https://doi.org/10.1038/s41388-018-0194-3
Zhang, Jingwen ; Dulak, Austin M. ; Hattersley, Maureen M. ; Willis, Brandon S. ; Nikkilä, Jenni ; Wang, Anderson ; Lau, Alan ; Reimer, Corinne ; Zinda, Michael ; Fawell, Stephen E. ; Mills, Gordon ; Chen, Huawei. / BRD4 facilitates replication stress-induced DNA damage response. In: Oncogene. 2018 ; pp. 1-15.
@article{41fb74147fef4ae8853ad3acde53a3f3,
title = "BRD4 facilitates replication stress-induced DNA damage response",
abstract = "Previous reports have demonstrated that select cancers depend on BRD4 to regulate oncogenic gene transcriptional programs. Here we describe a novel role for BRD4 in DNA damage response (DDR). BRD4 associates with and regulates the function of pre-replication factor CDC6 and plays an indispensable part in DNA replication checkpoint signaling. Inhibition of BRD4 by JQ1 or AZD5153 resulted in a rapid, time-dependent reduction in CHK1 phosphorylation and aberrant DNA replication re-initiation. Furthermore, BRD4 inhibition sensitized cancer cells to various replication stress-inducing agents, and synergized with ATR inhibitor AZD6738 to induce cell killing across a number of cancer cell lines. The synergistic interaction between AZD5153 and AZD6738 is translatable to in vivo ovarian cell-line and patient-derived xenograft models. Taken together, our study uncovers a new biological function of BRD4 and provides mechanistic rationale for combining BET inhibitors with DDR-targeted agents for cancer therapy.",
author = "Jingwen Zhang and Dulak, {Austin M.} and Hattersley, {Maureen M.} and Willis, {Brandon S.} and Jenni Nikkil{\"a} and Anderson Wang and Alan Lau and Corinne Reimer and Michael Zinda and Fawell, {Stephen E.} and Gordon Mills and Huawei Chen",
year = "2018",
month = "4",
day = "11",
doi = "10.1038/s41388-018-0194-3",
language = "English (US)",
pages = "1--15",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - BRD4 facilitates replication stress-induced DNA damage response

AU - Zhang, Jingwen

AU - Dulak, Austin M.

AU - Hattersley, Maureen M.

AU - Willis, Brandon S.

AU - Nikkilä, Jenni

AU - Wang, Anderson

AU - Lau, Alan

AU - Reimer, Corinne

AU - Zinda, Michael

AU - Fawell, Stephen E.

AU - Mills, Gordon

AU - Chen, Huawei

PY - 2018/4/11

Y1 - 2018/4/11

N2 - Previous reports have demonstrated that select cancers depend on BRD4 to regulate oncogenic gene transcriptional programs. Here we describe a novel role for BRD4 in DNA damage response (DDR). BRD4 associates with and regulates the function of pre-replication factor CDC6 and plays an indispensable part in DNA replication checkpoint signaling. Inhibition of BRD4 by JQ1 or AZD5153 resulted in a rapid, time-dependent reduction in CHK1 phosphorylation and aberrant DNA replication re-initiation. Furthermore, BRD4 inhibition sensitized cancer cells to various replication stress-inducing agents, and synergized with ATR inhibitor AZD6738 to induce cell killing across a number of cancer cell lines. The synergistic interaction between AZD5153 and AZD6738 is translatable to in vivo ovarian cell-line and patient-derived xenograft models. Taken together, our study uncovers a new biological function of BRD4 and provides mechanistic rationale for combining BET inhibitors with DDR-targeted agents for cancer therapy.

AB - Previous reports have demonstrated that select cancers depend on BRD4 to regulate oncogenic gene transcriptional programs. Here we describe a novel role for BRD4 in DNA damage response (DDR). BRD4 associates with and regulates the function of pre-replication factor CDC6 and plays an indispensable part in DNA replication checkpoint signaling. Inhibition of BRD4 by JQ1 or AZD5153 resulted in a rapid, time-dependent reduction in CHK1 phosphorylation and aberrant DNA replication re-initiation. Furthermore, BRD4 inhibition sensitized cancer cells to various replication stress-inducing agents, and synergized with ATR inhibitor AZD6738 to induce cell killing across a number of cancer cell lines. The synergistic interaction between AZD5153 and AZD6738 is translatable to in vivo ovarian cell-line and patient-derived xenograft models. Taken together, our study uncovers a new biological function of BRD4 and provides mechanistic rationale for combining BET inhibitors with DDR-targeted agents for cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=85045149018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045149018&partnerID=8YFLogxK

U2 - 10.1038/s41388-018-0194-3

DO - 10.1038/s41388-018-0194-3

M3 - Article

SP - 1

EP - 15

JO - Oncogene

JF - Oncogene

SN - 0950-9232

ER -